European Union begins real-time review of Sanofi-GSK Covid vaccine

Europe's drug regulator said on Tuesday it had started a real-time review of the COVID-19 vaccine developed by French drugmaker Sanofi and Britain's GlaxoSmithKline, the fifth shot under such a review currently.
 

The decision to start the "rolling review" of the vaccine, Vidprevtyn, was based on preliminary results from lab studies and early stage clinical trials in adults, the European Medicines Agency (EMA) said https://www.ema.europa.eu/en/news/ema-starts-rolling-review-covid-19-vaccine-vidprevtyn.
 

Late-stage global trials for the protein-based coronavirus vaccine candidate began in May.
 

Sanofi and GSK hope to get approvals by the end of 2021 after early stage results showed the vaccine produces a robust immune